These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 10923665)
1. The zitter mutant rat exhibits loss of D3 receptors with degeneration of the dopamine system. Joyce JN; Yoshimoto K; Ueda S Neuroreport; 2000 Jul; 11(10):2173-5. PubMed ID: 10923665 [TBL] [Abstract][Full Text] [Related]
2. Loss of D3 receptors in the zitter mutant rat is not reversed by L-dopa treatment. Joyce JN; Der TC; Renish L; Osredkar T; Hagner D; Reploge M; Sakakibara S; Ueda S Exp Neurol; 2004 May; 187(1):178-89. PubMed ID: 15081599 [TBL] [Abstract][Full Text] [Related]
3. There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum. Thomas WS; Neal-Beliveau BS; Joyce JN Brain Res Dev Brain Res; 1998 Nov; 111(1):99-106. PubMed ID: 9804909 [TBL] [Abstract][Full Text] [Related]
4. Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations. Joyce JN; Renish L; Osredkar T; Walro JM; Kucera J; Dluzen DE Synapse; 2004 Apr; 52(1):11-9. PubMed ID: 14755628 [TBL] [Abstract][Full Text] [Related]
5. Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter. Fauchey V; Jaber M; Caron MG; Bloch B; Le Moine C Eur J Neurosci; 2000 Jan; 12(1):19-26. PubMed ID: 10651856 [TBL] [Abstract][Full Text] [Related]
6. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine. Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Costa D; Perry RH; Perry EK Neuroscience; 1999 May; 90(2):433-45. PubMed ID: 10215149 [TBL] [Abstract][Full Text] [Related]
7. [125I]Epibatidine-labelled nicotinic receptors in the extended striatum and cerebral cortex: lack of association with serotonergic afferents. Pradhan AA; Cumming P; Clarke PB Brain Res; 2002 Nov; 954(2):227-36. PubMed ID: 12414106 [TBL] [Abstract][Full Text] [Related]
8. Distribution of cocaine recognition sites in rat brain: in vitro and ex vivo autoradiography with [125I]RTI-55. Fujita M; Shimada S; Fukuchi K; Tohyama M; Nishimura T J Chem Neuroanat; 1994 Jul; 7(1-2):13-23. PubMed ID: 7802967 [TBL] [Abstract][Full Text] [Related]
9. Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex. Flores G; Wood GK; Liang JJ; Quirion R; Srivastava LK J Neurosci; 1996 Nov; 16(22):7366-75. PubMed ID: 8929443 [TBL] [Abstract][Full Text] [Related]
10. Selective regulation of dopamine transporter binding in the shell of the nucleus accumbens by adrenalectomy and corticosterone-replacement. Sarnyai Z; McKittrick CR; McEwen BS; Kreek MJ Synapse; 1998 Nov; 30(3):334-7. PubMed ID: 9776137 [No Abstract] [Full Text] [Related]
11. Discovery of novel peptidic dopamine transporter ligands by screening a positional scanning combinatorial hexapeptide library. Rothman RB; Baumann MH; Dersch CM; Appel J; Houghten RA Synapse; 1999 Sep; 33(3):239-46. PubMed ID: 10420171 [TBL] [Abstract][Full Text] [Related]
12. Repeated treatment with the selective kappa opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors. Izenwasser S; Acri JB; Kunko PM; Shippenberg T Synapse; 1998 Nov; 30(3):275-83. PubMed ID: 9776131 [TBL] [Abstract][Full Text] [Related]
13. Prenatal cocaine exposure affects postnatal dopaminergic systems in various regions of the rat brain. Choi SJ; Mazzio E; Kolta MG; Soliman KF Ann N Y Acad Sci; 1998 May; 844():293-302. PubMed ID: 9668686 [TBL] [Abstract][Full Text] [Related]
14. Brain dopamine transporter in spontaneously hypertensive rats. Watanabe Y; Fujita M; Ito Y; Okada T; Kusuoka H; Nishimura T J Nucl Med; 1997 Mar; 38(3):470-4. PubMed ID: 9074541 [TBL] [Abstract][Full Text] [Related]
15. Lewis and Fischer rats: a comparison of dopamine transporter and receptors levels. Flores G; Wood GK; Barbeau D; Quirion R; Srivastava LK Brain Res; 1998 Dec; 814(1-2):34-40. PubMed ID: 9838033 [TBL] [Abstract][Full Text] [Related]
16. Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease. Ryoo HL; Pierrotti D; Joyce JN Mov Disord; 1998 Sep; 13(5):788-97. PubMed ID: 9756147 [TBL] [Abstract][Full Text] [Related]
17. Visualization of ischemic insult in caudate putamen with beta-CIT. Fujita M; Shimada S; Tohyama M; Nishimura T J Nucl Med; 1996 Jul; 37(7):1214-8. PubMed ID: 8965201 [TBL] [Abstract][Full Text] [Related]
18. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding. Rothman RB; Dersch CM; Carroll FI; Ananthan S Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522 [TBL] [Abstract][Full Text] [Related]
19. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys. Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626 [TBL] [Abstract][Full Text] [Related]
20. Preferential vulnerability of nucleus accumbens dopamine binding sites to low-level lead exposure: time course of effects and interactions with chronic dopamine agonist treatments. Pokora MJ; Richfield EK; Cory-Slechta DA J Neurochem; 1996 Oct; 67(4):1540-50. PubMed ID: 8858938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]